Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Gastrectomy methods"'
Autor:
Katrine Brodersen, Michael F. Nielsen, Bjørn Richelsen, Esben S. Lauritzen, Einar Pahle, Jan Abrahamsen, Bolette Hartmann, Jens J. Holst, Niels Møller
Publikováno v:
Brodersen, K, Nielsen, M F, Richelsen, B, Lauritzen, E S, Pahle, E, Abrahamsen, J, Hartmann, B, Holst, J J & Møller, N 2022, ' Comparable Effects of Sleeve Gastrectomy and Roux-en-Y Gastric Bypass on Basal Fuel Metabolism and Insulin Sensitivity in Individuals with Obesity and Type 2 Diabetes ', Journal of Diabetes Research, vol. 2022, 5476454 . https://doi.org/10.1155/2022/5476454
Aim. Bariatric surgery improves insulin sensitivity and glucose tolerance in obese individuals with type 2 diabetes (T2D), but there is a lack of data comparing the underlying metabolic mechanisms after the 2 most common surgical procedures Roux-en-Y
Publikováno v:
Revue medicale suisse, vol. 18, no. 774, pp. 531-534
Two main procedures currently dominate the panel of bariatric interventions. Sleeve gastrectomy is technically easier and the most widely performed in the world. It shows slightly inferior results and is also associated with a slightly lower morbidit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1900::4dd921690102b06e1e6497da620d6c31
https://serval.unil.ch/notice/serval:BIB_EF38FDF0A890
https://serval.unil.ch/notice/serval:BIB_EF38FDF0A890
Autor:
Sérgio Santoro, Manoel Carlos Prieto Velhote, Carlos Eduardo Malzoni, Alexandre Sérgio Gracia Mechenas, Victor Strassmann, Morton Scheinberg
Publikováno v:
Einstein (São Paulo), Vol 1, Iss 2, Pp 99-104 (2003)
Objective: To report on a new surgical technique to treat obesity -Digestive Adaptation - and to present its preliminary results.Method: The technique includes a vertical (sleeve) gastrectomy,omentectomy and enterectomy maintaining the initial 150-cm
Externí odkaz:
https://doaj.org/article/398131bf22c6490db87e0d9324b1a715
Autor:
Shinichi Kinami, Hideto Fujita, Takashi Miyata, Yasuto Tomita, Takeo Kosaka, Naohiko Nakamura, Nobuhiko Ueda
Publikováno v:
World Journal of Gastroenterology
The gravest prognostic factor in early gastric cancer is lymph-node metastasis, with an incidence of about 10% overall. About two-thirds of early gastric cancer patients can be diagnosed as node-negative prior to treatment based on clinic-pathologica
Autor:
Ana Varela, Davide Carvalho, Guerreiro, Maria João Ferreira, Paula Freitas, Daniela Magalhaes, Sandra Belo, Jorge Pedro, Sofia Castro Oliveira, Pedro Souteiro, João Sérgio Neves, Daniela Salazar
Publikováno v:
Obesity Facts, Vol 12, Iss 6, Pp 639-652 (2019)
Introduction: Bariatric surgery is an effective treatment for morbid obesity and its metabolic related comorbidities. However, the literature reports inconsistent results regarding weight loss (WL) and the resolution of comorbidities associated with
Autor:
Gertsen, E. C., Brenkman, H. J.F., Seesing, M. F.J., Goense, L., Ruurda, J. P., van Hillegersberg, R., Dutch Upper Gastrointestinal Cancer Audit (DUCA) group
BACKGROUND: Minimally invasive gastrectomy has been introduced in Western populations during the last decade. As minimally invasive distal gastrectomy (MIDG) versus total gastrectomy (MITG) are procedures with a different complexity, outcomes may dif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10691::e8e6f7bc87c533f07eb2e634ab9eae4f
https://dspace.library.uu.nl/handle/1874/381380
https://dspace.library.uu.nl/handle/1874/381380
Autor:
Astrid E. Slagter, Maarten C.C.M. Hulshof, Grard A. P. Nieuwenhuijzen, Edwin P.M. Jansen, Geke A. P. Hospers, Richard van Hillegersberg, Karolina Sikorska, Maartje Los, Donald L. van der Peet, Mark I. van Berge Henegouwen, Hanneke W. M. van Laarhoven, Henk Boot, Nicole C.T. van Grieken, Boudewijn van Etten, Annemieke Cats, Johanna W. van Sandick, Henk H. Hartgrink, Heike I. Grabsch, Marcel Verheij, Laurens V. Beerepoot, Pietje Muller-Timmermans, Frank P. J. Peters
Publikováno v:
BMC Cancer, 18(1):877. BioMed Central Ltd
BMC Cancer, Vol 18, Iss 1, Pp 1-12 (2018)
BMC Cancer, 18:877. BMC
BMC Cancer, 18
BMC cancer, 18(1). BioMed Central
BMC Cancer, 18(1). BioMed Central
BMC Cancer
BMC Cancer, 18. BMC
Slagter, A E, Jansen, E P M, van Laarhoven, H W M, van Sandick, J W, van Grieken, N C T, Sikorska, K, Cats, A, Muller-Timmermans, P, Hulshof, M C C M, Boot, H, Los, M, Beerepoot, L V, Peters, F P J, Hospers, G A P, van Etten, B, Hartgrink, H H, van Berge Henegouwen, M I, Nieuwenhuijzen, G A P, van Hillegersberg, R, van der Peet, D L, Grabsch, H I & Verheij, M 2018, ' CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer ', BMC Cancer, vol. 18, no. 1, pp. 877 . https://doi.org/10.1186/s12885-018-4770-2
BMC Cancer, Vol 18, Iss 1, Pp 1-12 (2018)
BMC Cancer, 18:877. BMC
BMC Cancer, 18
BMC cancer, 18(1). BioMed Central
BMC Cancer, 18(1). BioMed Central
BMC Cancer
BMC Cancer, 18. BMC
Slagter, A E, Jansen, E P M, van Laarhoven, H W M, van Sandick, J W, van Grieken, N C T, Sikorska, K, Cats, A, Muller-Timmermans, P, Hulshof, M C C M, Boot, H, Los, M, Beerepoot, L V, Peters, F P J, Hospers, G A P, van Etten, B, Hartgrink, H H, van Berge Henegouwen, M I, Nieuwenhuijzen, G A P, van Hillegersberg, R, van der Peet, D L, Grabsch, H I & Verheij, M 2018, ' CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer ', BMC Cancer, vol. 18, no. 1, pp. 877 . https://doi.org/10.1186/s12885-018-4770-2
Contains fulltext : 196889.pdf (Publisher’s version ) (Open Access) BACKGROUND: Although radical surgery remains the cornerstone of cure in resectable gastric cancer, survival remains poor. Current evidence-based (neo)adjuvant strategies have shown
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29e7b8e7e788dd757dd2f7cc71f3dbf2
https://eprints.whiterose.ac.uk/136426/1/12885_2018_Article_4770.pdf
https://eprints.whiterose.ac.uk/136426/1/12885_2018_Article_4770.pdf
Publikováno v:
Nederlands Tijdschrift voor Geneeskunde. 162(7)
BACKGROUND: Obesity is a chronic disease and a risk factor for heart failure. In end-stage heart failure, heart transplantation may be the only available treatment option, but obesity is a contraindication for this treatment because of its unfavourab
Publikováno v:
Nederlands Tijdschrift voor Geneeskunde. 162(7)
BACKGROUND: Obesity is a chronic disease and a risk factor for heart failure. In end-stage heart failure, heart transplantation may be the only available treatment option, but obesity is a contraindication for this treatment because of its unfavourab
Autor:
Botter, Bente, Koolen, Eric, van Montfort, Gust, Bracke, Frank A.L.E., Bouwman, Arthur, Buise, Marc
Publikováno v:
Nederlands Tijdschrift voor Geneeskunde, 162(7):d1972. Bohn Stafleu van Loghum
BACKGROUND: Obesity is a chronic disease and a risk factor for heart failure. In end-stage heart failure, heart transplantation may be the only available treatment option, but obesity is a contraindication for this treatment because of its unfavourab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::c850827cff91ea1d7f00d031aaad2af4
https://research.tue.nl/nl/publications/92a64d50-e4b7-4326-8a7a-e70814c5c3ea
https://research.tue.nl/nl/publications/92a64d50-e4b7-4326-8a7a-e70814c5c3ea